• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Francis J. Hornicek, MD, PhD


  • Wojcik JB, Bellizzi AM, Dal Cin P, Bredella MA, Fletcher CD, Hornicek FJ, Deshpande V, Hornick JL, Nielsen GP.Primary Sclerosing Epithelioid Fibrosarcoma of Bone: Analysis of a Series.Am J Surg Pathol. 2014 Jun 11.
  • Shen JK, Cote GM, Choy E, Yang P, Harmon D, Schwab J, Nielsen GP, Chebib I, Ferrone S, Wang X, Wang Y, Mankin H, Hornicek FJ, Duan Z.Programmed Cell Death Ligand 1 Expression in Osteosarcoma.Cancer Immunol Res. 2014 Apr 21.
  • Cipriani NA, Kurzawa P, Ahmad RA, Deshpande V, Hornicek FJ, Mullen JT, Nielsen GP.Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.Hum Pathol. 2014 Mar 26.
  • Osaka E, Yang X, Shen JK, Yang P, Feng Y, Mankin HJ, Hornicek FJ, Duan Z.MicroRNA-1 (miR-1) inhibits chordoma cell migration and invasion by targeting slug.J Orthop Res. 2014 Apr 24.
  • Delaney TF, Liebsch NJ, Pedlow FX, Adams J, Weyman EA, Yeap BY, Depauw N, Nielsen GP, Harmon DC, Yoon SS, Chen YL, Schwab JH, Hornicek FJ.Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas.J Surg Oncol. 2014 Apr 19.
  • Cheney MD, Giraud C, Goldberg SI, Rosenthal DI, Hornicek FJ, Choy E, Mullen JT, Chen YL, Delaney TF.MRI surveillance following treatment of extremity soft tissue sarcoma.J Surg Oncol. 2014 May;109(6):593-6.
  • Guo S, Lopez-Marquez H, Fan KC, Choy E, Cote G, Harmon D, Nielsen GP, Yang C, Zhang C, Mankin H, Hornicek FJ, Borger DR, Duan Z.Synergistic Effects of Targeted PI3K Signaling Inhibition and Chemotherapy in Liposarcoma.PLoS ONE. 2014;9(4):e93996.
  • Colman MW, Lozano-Calderon S, Raskin KA, Hornicek FJ, Gebhardt M.Non-neoplastic Soft Tissue Masses That Mimic Sarcoma.Orthop. Clin. North Am. 2014 Apr;45(2):245-255.
  • Cipriani NA, Letovanec I, Hornicek FJ, Mullen JT, Duan Z, Borger DR, Nielsen GP.BRAF mutation in 'sarcomas': a possible method to detect de-differentiated melanomas.Histopathology. 2014 Apr;64(5):639-46.
  • Teunis T, Nota SP, Hornicek FJ, Schwab JH, Lozano-Calderón SA.Outcome After Reconstruction of the Proximal Humerus for Tumor Resection: A Systematic Review.Clin Orthop Relat Res. 2014 Jan 28.
  • Boyaci B, Hornicek FJ, Nielsen GP, DeLaney TF, Pedlow FX, Mansfield FL, Carrier CS, Harms J, Schwab JH.Epithelioid hemangioma of the spine: a case series of six patients and review of the literature.Spine J. 2013 Dec;13(12):e7-13.
  • Zhang L, Guo S, Schwab JH, Nielsen GP, Choy E, Ye S, Zhang Z, Mankin H, Hornicek FJ, Duan Z.Tissue microarray immunohistochemical detection of brachyury is not a prognostic indicator in chordoma.PLoS ONE. 2013;8(9):e75851.
  • Mullen JT, DeLaney TF, Rosenberg AE, Le L, Iafrate AJ, Kobayashi W, Szymonifka J, Yeap BY, Chen YL, Harmon DC, Choy E, Yoon SS, Raskin KA, Hornicek FJ, Nielsen GP.β-Catenin mutation status and outcomes in sporadic desmoid tumors.Oncologist. 2013;18(9):1043-9.
  • Kurzawa P, Kattapuram S, Hornicek FJ, Antonescu CR, Rosenberg AE, Nielsen GP.Primary myoepithelioma of bone: a report of 8 cases.Am J Surg Pathol. 2013 Jul;37(7):960-8.
  • Biermann JS, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Butrynski JE, Cheong D, Chow W, Curry WT, Frassica DA, Frassica FJ, Hande KR, Hornicek FJ, Jones RL, Mayerson J, McGarry SV, McGrath B, Morris CD, O'Donnell RJ, Randall RL, Santana VM, Satcher RL, Siegel HJ, von Mehren M, Bergman MA, Sundar H.Bone cancer.J Natl Compr Canc Netw. 2013 Jun 1;11(6):688-723.
  • Kerr DA, Lopez HU, Deshpande V, Hornicek FJ, Duan Z, Zhang Y, Rosenberg AE, Borger DR, Nielsen GP.Molecular Distinction of Chondrosarcoma From Chondroblastic Osteosarcoma Through IDH1/2 Mutations.Am J Surg Pathol. 2013 Apr 16.
  • Kang J, Botros M, Goldberg S, Giraud C, Nielsen GP, Chen YL, Raskin K, Schwab J, Yoon SS, Hornicek FJ, Delaney TF.The use of radiation therapy in the management of selected patients with atypical lipomas.Sarcoma. 2013;2013:485483.
  • Dunn GP, Spiliopoulos K, Plotkin SR, Hornicek FJ, Harmon DC, Delaney TF, Williams Z.Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis Type 1.J Neurosurg. 2012 Oct 26.
  • Hong NJ, Hornicek FJ, Harmon DC, Choy E, Chen YL, Yoon SS, Nielsen GP, Szymonifka J, Yeap BY, Delaney TF, Mullen JT.Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: A 10-year single institution retrospective study.Eur J Cancer. 2012 Oct 20.
  • Schwab JH, Springfield DS, Raskin KA, Mankin HJ, Hornicek FJ.What's New in Primary Bone Tumors.J Bone Joint Surg Am. 2012 Oct 17;94(20):1913-9.
  • Kobayashi E, Iyer AK, Hornicek FJ, Amiji MM, Duan Z.Lipid-functionalized Dextran Nanosystems to Overcome Multidrug Resistance in Cancer: A Pilot Study.Clin Orthop Relat Res. 2012 Sep 21.
  • Stylianopoulos T, Martin JD, Chauhan VP, Jain SR, Diop-Frimpong B, Bardeesy N, Smith BL, Ferrone CR, Hornicek FJ, Boucher Y, Munn LL, Jain RK.Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors.Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15101-8.
  • Yang W, Liu X, Choy E, Mankin H, Hornicek FJ, Duan Z.Targeting hedgehog-GLI-2 pathway in osteosarcoma.J Orthop Res. 2012 Sep 11.
  • Mullen JT, Delaney TF, Kobayashi WK, Szymonifka J, Yeap BY, Chen YL, Rosenberg AE, Harmon DC, Choy E, Yoon SS, Raskin KA, Petur Nielsen G, Hornicek FJ.Desmoid Tumor: Analysis of Prognostic Factors and Outcomes in a Surgical Series.Ann Surg Oncol. 2012 Sep 11.
  • Duan Z, Zhang J, Choy E, Harmon D, Liu X, Nielsen P, Mankin H, Gray NS, Hornicek FJ.Systematic Kinome shRNA Screening Identifies CDK11 (PITSLRE) Kinase Expression Is Critical for Osteosarcoma Cell Growth and Proliferation.Clin Cancer Res. 2012 Sep 1;18(17):4580-8.
  • Liu X, Nielsen GP, Rosenberg AE, Waterman PR, Yang W, Choy E, Sassi S, Yang S, Harmon DC, Yang C, Schwab JH, Kobayashi E, Mankin HJ, Xavier R, Weissleder R, Duan Z, Hornicek FJ.Establishment and characterization of a novel chordoma cell line: CH22.J Orthop Res. 2012 Oct;30(10):1666-73.
  • Look Hong NJ, Hornicek FJ, Raskin KA, Yoon SS, Szymonifka J, Yeap B, Chen YL, Delaney TF, Nielsen GP, Mullen JT.Prognostic Factors and Outcomes of Patients with Myxofibrosarcoma.Ann Surg Oncol. 2012 Aug 14.
  • Ciernik IF, Niemierko A, Harmon DC, Kobayashi W, Chen YL, Yock TI, Ebb DH, Choy E, Raskin KA, Liebsch N, Hornicek FJ, Delaney TF.Proton-based radiotherapy for unresectable or incompletely resected osteosarcoma.Cancer. 2011 Mar 29.
  • Liu X, Choy E, Harmon D, Yang S, Yang C, Mankin H, Hornicek FJ, Duan Z.Inhibition of polo-like kinase 1 leads to the suppression of osteosarcoma cell growth in vitro and in vivo.Anti Cancer Drugs. 2011 Mar 10.
  • Liu X, Choy E, Hornicek FJ, Yang S, Yang C, Harmon D, Mankin H, Duan Z.ROCK1 as a potential therapeutic target in osteosarcoma.J Orthop Res. 2011 Mar 8.
  • Henderson ER, Groundland JS, Pala E, Dennis JA, Wooten R, Cheong D, Windhager R, Kotz RI, Mercuri M, Funovics PT, Hornicek FJ, Temple HT, Ruggieri P, Letson GD.Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review.J Bone Joint Surg Am. 2011 Mar;93(5):418-29.
  • Susa M, Choy E, Liu X, Schwab JH, Hornicek FJ, Mankin H, Duan Z.Cyclin G-associated kinase is necessary for osteosarcoma cell proliferation and receptor trafficking.Mol Cancer Ther. 2010 Dec;9(12):3342-50.
  • Guo Y, Nemeth JA, O'Brien C, Susa M, Liu X, Zhang Z, Choy E, Mankin H, Hornicek FJ, Duan Z.Effects of Siltuximab on the IL-6 Induced Signaling Pathway in Ovarian Cancer.Clin Cancer Res. 2010 Dec 1;16(23):5759-69.
  • Tejwani A, Kobayashi W, Chen YL, Rosenberg AE, Yoon S, Raskin KA, Rosenthal DI, Nielsen GP, Hornicek FJ, Delaney TF.Management of acral myxoinflammatory fibroblastic sarcoma.Cancer. 2010 Dec 15;116(24):5733-9.
  • DeLaney TF, Duan Z, Hornicek FJ.Proteomic profiling of chordoma.J Surg Oncol. 2010 Dec 1;102(7):719.
  • Yoon SS, Duda DG, Karl DL, Kim TM, Kambadakone AR, Chen YL, Rothrock C, Rosenberg AE, Nielsen GP, Kirsch DG, Choy E, Harmon DC, Hornicek FJ, Dreyfuss J, Ancukiewicz M, Sahani DV, Park PJ, Jain RK, Delaney TF.Phase II Study of Neoadjuvant Bevacizumab and Radiotherapy for Resectable Soft Tissue Sarcomas.Int J Radiat Oncol Biol Phys. 2010 Oct 5.
  • Mankin HJ, Hornicek FJ, Springfield DS.Extra-abdominal desmoid tumors: A report of 234 cases.J Surg Oncol. 2010 Oct 1;102(5):380-4.
  • Devisetty K, Kobayashi W, Suit HD, Goldberg SI, Niemierko A, Chen YL, Raskin KA, Schwab JH, Springfield DS, Yoon SS, Hornicek FJ, Delaney TF.Low-Dose Neoadjuvant External Beam Radiation Therapy for Soft Tissue Sarcoma.Int J Radiat Oncol Biol Phys. 2010 Sep 21.
  • Yang C, Hornicek FJ, Wood KB, Schwab JH, Choy E, Mankin H, Duan Z.Blockage of Stat3 With CDDO-Me Inhibits Tumor Cell Growth in Chordoma.Spine. 2010 Aug 15;35(18):1668-75.
  • Schoenfeld AJ, Hornicek FJ, Pedlow FX, Kobayashi W, Garcia RT, DeLaney TF, Springfield D, Mankin HJ, Schwab JH.Osteosarcoma of the spine: experience in 26 patients treated at the Massachusetts General Hospital.Spine J. 2010 Aug;10(8):708-14.
  • Biermann JS, Adkins DR, Benjamin RS, Brigman B, Chow W, Conrad EU, Frassica DA, Frassica FJ, George S, Hande KR, Hornicek FJ, Letson GD, Mayerson J, McGarry SV, McGrath B, Morris CD, O'Donnell RJ, Randall RL, Santana VM, Satcher RL, Siegel HJ, Somaiah N, Yasko AW.Bone cancer.J Natl Compr Canc Netw. 2010 Jun;8(6):688-712.
  • Susa M, Iyer AK, Ryu K, Choy E, Hornicek FJ, Mankin H, Milane L, Amiji MM, Duan Z.Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.PLoS ONE. 2010;5(5):e10764.
  • Yang C, Hornicek FJ, Wood KB, Schwab JH, Choy E, Iafrate J, Rosenberg A, Nielsen GP, Xavier RJ, Mankin H, Duan Z.Characterization and analysis of human chordoma cell lines.Spine. 2010 Jun 1;35(13):1257-64.
  • Kim B, Chen YL, Kirsch DG, Goldberg SI, Kobayashi W, Hyun Kung J, Wolfgang JA, Doppke K, Rosenberg AE, Nielsen GP, Raskin KA, Springfield DS, Schwab JH, Gebhardt MC, Yoon SS, Hornicek FJ, Delaney TF.An Effective Preoperative Three-Dimensional Radiotherapy Target Volume for Extremity Soft Tissue Sarcoma and the Effect of Margin Width on Local Control.Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):843-50.
  • Susa M, Milane L, Amiji MM, Hornicek FJ, Duan Z.Nanoparticles: A Promising Modality in the Treatment of Sarcomas.Pharmaceutical Research. 2010 May 27.
  • Ryu K, Susa M, Choy E, Yang C, Hornicek FJ, Mankin HJ, Duan Z.Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.BMC Cancer. 2010;10:187.
  • Ryu K, Choy E, Yang C, Susa M, Hornicek FJ, Mankin H, Duan Z.Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis.J Orthop Res. 2010 Jul;28(7):971-8.
  • Yang C, Choy E, Hornicek FJ, Wood KB, Schwab JH, Liu X, Mankin H, Duan Z.Histone deacetylase inhibitor (HDACI) PCI-24781 potentiates cytotoxic effects of doxorubicin in bone sarcoma cells.Cancer Chemother Pharmacol. 2010 May 12.
  • Koplin SA, Nielsen GP, Hornicek FJ, Rosenberg AE.Epithelioid Sarcoma With Heterotopic Bone: A Morphologic Review of 4 Cases.Int J Surg Pathol. 2010 Jun;18(3):207-12.
  • Duan Z, Ji D, Weinstein EJ, Liu X, Susa M, Choy E, Yang C, Mankin H, Hornicek FJ.Lentiviral shRNA screen of human kinases identifies PLK1 as a potential therapeutic target for osteosarcoma.Cancer Lett. 2010 Jul 28;293(2):220-9.
  • Duan Z, Choy E, Nielsen GP, Rosenberg A, Iafrate J, Yang C, Schwab J, Mankin H, Xavier R, Hornicek FJ.Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression.J Orthop Res. 2010 Jun;28(6):746-52.
  • Schoenfeld AJ, Koplin SA, Garcia R, Hornicek FJ, Mankin HJ, Raskin KA, Springfield D, Rosenberg AE, Schwab JH.Monostotic fibrous dysplasia of the spine: a report of seven cases.J Bone Joint Surg Am. 2010 Apr;92(4):984-8.
  • Yang C, Ji D, Weinstein EJ, Choy E, Hornicek FJ, Wood KB, Liu X, Mankin H, Duan Z.The Kinase Mirk is a Potential Therapeutic Target in Osteosarcoma.Carcinogenesis. 2010 Apr;31(4):552-8.
  • Susa M, Choy E, Yang C, Schwab J, Mankin H, Hornicek F, Duan Z.Multidrug resistance reversal agent, NSC77037, identified with a cell-based screening assay.J Biomol Screen. 2010 Mar;15(3):287-96.
  • Resnick CM, Margolis J, Susarla SM, Schwab JH, Hornicek FJ, Dodson TB, Kaban LB.Maxillofacial and axial/appendicular giant cell lesions: unique tumors or variants of the same disease?--A comparison of phenotypic, clinical, and radiographic characteristics.J Oral Maxillofac Surg. 2010 Jan;68(1):130-7.
  • Susa M, Iyer AK, Ryu K, Hornicek FJ, Mankin H, Amiji MM, Duan Z.Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.BMC Cancer. 2009;9:399.
  • Mito JK, Riedel RF, Dodd L, Lahat G, Lazar AJ, Dodd RD, Stangenberg L, Eward WC, Hornicek FJ, Yoon SS, Brigman BE, Jacks T, Lev D, Mukherjee S, Kirsch DG.Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma/malignant fibrous histiocytoma.PLoS ONE. 2009;4(11):e8075.
  • Duan Z, Choy E, Hornicek FJ.NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance.PLoS ONE. 2009;4(10):e7415.
  • Yang C, Schwab JH, Schoenfeld AJ, Hornicek FJ, Wood KB, Nielsen GP, Choy E, Mankin H, Duan Z.A novel target for treatment of chordoma: signal transducers and activators of transcription 3.Mol Cancer Ther. 2009 Sep;8(9):2597-605.
  • Duan Z, Choy E, Harmon D, Yang C, Ryu K, Schwab J, Mankin H, Hornicek FJ.ZNF93 increases resistance to ET-743 (Trabectedin; Yondelis) and PM00104 (Zalypsis) in human cancer cell lines.PLoS ONE. 2009;4(9):e6967.
  • Duan Z, Choy E, Harmon D, Yang C, Ryu K, Schwab J, Mankin H, Hornicek FJ.Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.Mol Cancer Ther. 2009 Aug;8(8):2122-30.
  • Susa M, Morii T, Yabe H, Horiuchi K, Toyama Y, Weissbach L, Hornicek FJ, Morioka H.Alendronate inhibits growth of high-grade chondrosarcoma cells.Anticancer Res. 2009 Jun;29(6):1879-88.
  • Schwab J, Antonescu C, Boland P, Healey J, Rosenberg A, Nielsen P, Iafrate J, Delaney T, Yoon S, Choy E, Harmon D, Raskin K, Yang C, Mankin H, Springfield D, Hornicek F, Duan Z.Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma.Anticancer Res. 2009 Jun;29(6):1867-71.
  • Yang C,Hornicek FJ,Wood KB,Schwab JH,Mankin H,Duan Z.RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.Cancer Chemother Pharmacol. 2009 Aug;64(3):607-14.
  • Han S,Polizzano C,Nielsen GP,Hornicek FJ,Rosenberg AE,Ramesh V.Aberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomas.Clin Cancer Res. 2009 Mar 15;15(6):1940-6.
  • Maduekwe UN,Hornicek FJ,Springfield DS,Raskin KA,Harmon DC,Choy E,Rosenberg AE,Nielsen GP,DeLaney TF,Chen YL,Ott MJ,Yoon SS.Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas.Ann Surg Oncol. 2009 May;16(5):1356-63.
  • Sapkota BH,Hirsch AE,Yoo AJ,Hornicek FJ,Raskin KA,Rosenthal DI,Growney ML,Hirsch JA.Treatment of metastatic carcinoma to the hip with CT-guided percutaneous acetabuloplasty: report of four cases.J Vasc Interv Radiol. 2009 Apr;20(4):548-52.
  • Wagner TD,Kobayashi W,Dean S,Goldberg SI,Kirsch DG,Suit HD,Hornicek FJ,Pedlow FX,Raskin KA,Springfield DS,Yoon SS,Gebhardt MC,Mankin HJ,Delaney TF.Combination short-course preoperative irradiation, surgical resection, and reduced-field high-dose postoperative irradiation in the treatment of tumors involving the bone.Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):259-66.
  • DeLaney TF,Liebsch NJ,Pedlow FX,Adams J,Dean S,Yeap BY,McManus P,Rosenberg AE,Nielsen GP,Harmon DC,Spiro IJ,Raskin KA,Suit HD,Yoon SS,Hornicek FJ.Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):732-9.
  • Yang C,Yang S,Wood KB,Hornicek FJ,Schwab JH,Fondren G,Mankin H,Duan Z.Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression.Apoptosis. 2009 Jan;14(1):124-33.
  • Duan Z,Choy E,Jimeno JM,Cuevas Cdel M,Mankin HJ,Hornicek FJ.Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines.Cancer Chemother Pharmacol. 2009 May;63(6):1121-9.
  • Duan Z,Weinstein EJ,Ji D,Ames RY,Choy E,Mankin H,Hornicek FJ.Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer.Mol Cancer Ther. 2008 Aug;7(8):2377-85.
  • Sung AD,Anderson ME,Zurakowski D,Hornicek FJ,Gebhardt MC.Unicameral bone cyst: a retrospective study of three surgical treatments.Clin Orthop Relat Res. 2008 Oct;466(10):2519-26.
  • Parrett BM,Winograd JM,Garfein ES,Lee WP,Hornicek FJ,Austen WG Jr.The vertical and extended rectus abdominis myocutaneous flap for irradiated thigh and groin defects.Plast Reconstr Surg. 2008 Jul;122(1):171-7.
  • Duan Z,Ames RY,Ryan M,Hornicek FJ,Mankin H,Seiden MV.CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.Cancer Chemother Pharmacol. 2009 Mar;63(4):681-9.
  • Sawamura C, Hornicek FJ, Gebhardt MC.Complications and Risk Factors for Failure of Rotationplasty: Review of 25 Patients.Clin Orthop Relat Res. 2008 Jun;466(6):1302-8.
  • Kharrazi FD, Busfield BT, Khorshad DS, Hornicek FJ, Mankin HJ.Osteoarticular and total elbow allograft reconstruction with severe bone loss.Clin Orthop Relat Res. 2008 Jan;466(1):205-9.
  • Bredella MA, Torriani M, Hornicek F, Ouellette HA, Plamer WE, Williams Z, Fischman AJ, Plotkin SR.Value of PET in the assessment of patients with neurofibromatosis type 1.AJR Am J Roentgenol. 2007 Oct;189(4):928-35.
  • Kirsch DG, Dinulescu DM, Miller JB, Grimm J, Santiago PM, Young NP, Nielsen GP, Quade BJ, Chaber CJ, Schultz CP, Takeuchi O, Bronson RT, Crowley D, Korsmeyer SJ, Yoon SS, Hornicek FJ, Weissleder R, Jacks T.A spatially and temporally restricted mouse model of soft tissue sarcoma.Nat Med. 2007 Aug;13(8):992-7.
  • Hornicek FJ.RE: local control in nonmetastatic pelvic Ewing's sarcoma patients: Outcome and analysis, by Donati, D, et al.J Surg Oncol. 2007 Nov 1;96(6):453-4.
  • Sah AP, Geller DS, Mankin HJ, Rosenberg AE, Delaney TF, Wright CD, Hornicek FJ.Malignant transformation of synovial chondromatosis of the shoulder to chondrosarcoma. A case report.J Bone Joint Surg Am. 2007 Jun;89(6):1321-8.
  • Abraham JA, Hornicek FJ, Kaufman AM, Harmon DC, Springfield DS, Raskin KA, Mankin HJ, Kirsch DG, Rosenberg AE, Nielsen GP, Desphpande V, Suit HD, Delaney TF, Yoon SS.Treatment and Outcome of 82 Patients with Angiosarcoma.Ann Surg Oncol. 2007 Jun;14(6):1953-67.
  • Mourikis A, Mankin HJ, Hornicek FJ, Raskin KA.Treatment of proximal humeral chondrosarcoma with resection and allograft.J Shoulder Elbow Surg. 2007 Sep-Oct;16(5):519-24.
  • Geller DS, Hornicek FJ, Mankin HJ, Raskin KA.Soft tissue sarcoma resection volume associated with wound-healing complications.Clin Orthop Relat Res. 2007 Jun;459:182-5.
  • Kattapuram TM, Ozhathil DK, Hornicek FJ, Gebhardt MC, Mankin HJ, Rosenberg AE, Kattapuram SV.Imaging of pseudoneoplastic masses associated with allografts.Skeletal Radiol. 2007 Aug;36(8):747-53.
  • Buecker PJ, Berenstein M, Gebhardt MC, Hornicek FJ, Mankin HJ.Locking versus standard plates for allograft fixation after tumor resection in children and adolescents.J Pediatr Orthop. 2006 Sep-Oct;26(5):680-5.
  • Campbell J, Rosenthal DI, Raskin KA, Hornicek FJ, Michaelson MD.Use of an arterial tourniquet to achieve complete radiofrequency ablation of a renal metastasis.J Vasc Interv Radiol. 2006 Jun;17(6):1051-5.
  • Park L, Delaney TF, Liebsch NJ, Hornicek FJ, Goldberg S, Mankin H, Rosenberg AE, Rosenthal DI, Suit HD.Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor.Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1514-21.
  • Zeytoonjian T, Mankin HJ, Gebhardt MC, Hornicek FJ.Distal lower extremity sarcomas: frequency of occurrence and patient survival rate.Foot Ankle Int. 2004 May;25(5):325-30.
  • Lewandrowski KU, Hecht AC, DeLaney TF, Chapman PA, Hornicek FJ, Pedlow FX.Anterior spinal arthrodesis with structural cortical allografts and instrumentation for spine tumor surgery.Spine. 2004 May 15;29(10):1150-8; discussion 1159.
  • Brigman BE, Hornicek FJ, Gebhardt MC, Mankin HJ.Allografts about the Knee in Young Patients with High-Grade Sarcoma.Clin Orthop Relat Res. 2004 Apr(421):232-9.
  • Mankin HJ, Casas-Ganem J, Kim JI, Gebhardt MC, Hornicek FJ, Zeegen EN.Leiomyosarcoma of somatic soft tissues.Clin Orthop Relat Res. 2004 Apr(421):225-31.
  • Zeegen EN, Aponte-Tinao LA, Hornicek FJ, Gebhardt MC, Mankin HJ.Survivorship analysis of 141 modular metallic endoprostheses at early followup.Clin Orthop Relat Res. 2004 Mar(420):239-50.
  • Shao L, Kasanov J, Hornicek FJ, Morii T, Fondren G, Weissbach L.Ecteinascidin-743 drug resistance in sarcoma cells: transcriptional and cellular alterations.Biochem Pharmacol. 2003 Dec 15;66(12):2381-95.
  • Rosenthal DI, Hornicek FJ, Torriani M, Gebhardt MC, Mankin HJ.Osteoid osteoma: percutaneous treatment with radiofrequency energy.Radiology. 2003 Oct;229(1):171-5.
  • DeLaney TF, Chen GT, Mauceri TC, Munro JJ, Hornicek FJ, Pedlow FX, Suit HD.Intraoperative dural irradiation by customized 192iridium and 90yttrium brachytherapy plaques.Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):239-45.
  • DeLaney TF, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ, Rosenberg AL, Rosenthal DI, Miryousefi F, Ancukiewicz M, Harmon DC.Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1117-27.
  • Morioka H, Morii T, Vogel T, Hornicek FJ, Weissbach L.Interaction of plasminogen-related protein B with endothelial and smooth muscle cells in vitro.Exp Cell Res. 2003 Jul 1;287(1):166-77.
  • Rodriguez EK, Hornicek FJ, Gebhardt MC, Mankin HJ.Metachronous osteosarcoma: a report of five cases.Clin Orthop Relat Res. 2003 Jun(411):227-35.
  • Morioka H, Weissbach L, Vogel T, Nielsen GP, Faircloth GT, Shao L, Hornicek FJ.Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis.Clin Cancer Res. 2003 Mar;9(3):1211-7.
  • Rosenthal DI, Marota JJ, Hornicek FJ.Osteoid osteoma: elevation of cardiac and respiratory rates at biopsy needle entry into tumor in 10 patients.Radiology. 2003 Jan;226(1):125-8.